Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-15

Clinical Trial Update: Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a recombinant human interferon alfa-2b gel intended for cervical HPV-16/18 infections, spanning Phase 2 and Phase 3, with the status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Human Interferon alfa-2b Gel (Interferon alfa-2b)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Cervical HPV-16 and / or HPV-18 Infection | Phase 2, Phase 3 | Status: UNKNOWN